Metabolic syndrome

English

The IDF definition: why we need a global consensus

There is a constellation of metabolic abnormalities which includes centrally distributed obesity, decreased levels of HDL cholesterol, elevated triglycerides, high blood pressure, and high blood glucose (hyperglycaemia). This is known as the metabolic syndrome. Associated with a five-fold risk for type 2 diabetes and two- to three-fold increase in risk for cardiovascular disease, the metabolic syndrome is now considered one of the principal public health issues of the

The metabolic syndrome: a historical context

In the ongoing debates surrounding the metabolic syndrome, perhaps the key issue is whether this cluster of medical disorders arises from obesity or insensitivity to insulin. The lack of consensus on the principal underlying

What's in a name?

Editor-in-Chief's editorial

Time to plot a safe course

President's editorial

The endocannabinoid system: linking body weight, metabolic disorders and tobacco dependence

Treatment with the newly developed drug rimonabant has been found to help to reduce body weight and improve cardiovascular and metabolic risk factors. It has also been shown to help smokers to stop using tobacco without the weight gain often associated with cessation. Beat Lutz reports on the recently discovered body system that links obesity, metabolic disorders and smoking, and the potential of rimonabant as a therapeutic option to tackle these multiple cardiovascular risk factors.

Worsening the blow: the effects of smoking on diabetes complications

Cigarette smoking is a serious hazard to health. Yet, although as a group people with diabetes are at increased risk of developing cardiovascular disease, this does not appear to influence smoking habits among them. Tobacco use among people with diabetes is strongly associated with a further increase in the risk of developing cardiovascular complications. Furthermore, research has indicated that smoking has negative effects on the metabolism of glucose and lipids (fat), leading

Fighting diabetes and obesity: what has been done so far?

The urgent need to tackle obesity and prevent type 2 diabetes is now widely acknowledged, particularly by the health ministers worldwide who in May 2004 gave their unanimous approval to the World Health Organization (WHO) Global Strategy on Diet, Physical Activity and Health. Many health ministries around the world have policies to cope with these most pressing public health issues. But their detailed strategies are often unclear. Indeed, almost everywhere, national programmes to address obesity and diabetes are still under development.

A new IDF worldwide definition of the metabolic syndrome: the rationale and the results

The metabolic syndrome is one of the major public health issues of our time. The International Diabetes Federation (IDF) believes that this cluster of factors is driving the twin global epidemics of type 2 diabetes and cardiovascular disease. If current trends continue, the premature deaths and disabilities resulting from these conditions will cripple the health budgets of many nations – both developed and

Making clever use of simple tools

Editor-in-chief's editorial

The 1st International Congress on Prediabetes and the Metabolic Syndrome

The enormous impact of the metabolic syndrome on public health, and the exciting progress made in research into this field recently, led to the organization of the ‘1st

Pages